EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Determinants of Thiazide‐Induced Hyperuricemia, Hyperglycemia, and Urinary Electrolyte Disturbances – A Genome‐Wide Evaluation of the UK Biobank

Innocent G Asiimwe iD, Lauren Walker iD, Reecha Sofat iD, Andrea L Jorgensen iD, Munir Pirmohamed iD, Multimorbidity Mechanism and Therapeutic Research Collaborative (MMTRC)

Clinical Pharmacology & Therapeutics · 2024

DOI: 10.1002/cpt.3229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Innocent G Asiimwe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Hyperglycemia, Hyperuricemia, Polymorphism, Single Nucleotide, Sodium Chloride Symporter Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thiazide diuretics, widely used in hypertension, cause a variety of adverse reactions, including hyperglycemia, hyperuricemia, and electrolyte abnormalities. In this study, we aimed to identify genetic variants that interact with thiazide‐use to increase the risk of these adverse reactions. Using UK Biobank data, we first performed genomewide variance quantitative trait locus (vQTL) analysis of ~ 6.2 million SNPs on 95,493 unrelated hypertensive White British participants (24,313 on self‐reported bendroflumethiazide treatment at recruitment) for 2 blood (glucose and urate) and 2 urine (potassium and sodium) biomarkers. Second, we conducted direct gene–environment interaction (GEI) tests on the significant ( P < 2.5 × 10 −9 ) vQTLs, included a second UK Biobank cohort comprising 13,647 unrelated hypertensive White British participants (3,478 on thiazides other than bendroflumethiazide) and set significance at P = 0.05 divided by the number of vQTL SNPs tested for GEIs. The vQTL analysis identified eight statistically significant SNPs for blood glucose (5 SNPs) and serum urate (3 SNPs), with none being identified for the urinary biomarkers. Two of the SNPs (1 glucose SNP: CDKAL1 intron rs35612982, GEI P = 6.24 × 10 −3 ; and 1 serum urate SNP: SLC2A9 intron rs938564, GEI P = 4.51 × 10 −4 ) demonstrated significant GEI effects in the first, but not the second, cohort. Both genes are biologically plausible candidates, with the SLC2A9 ‐mediated interaction having been previously reported. In conclusion, we used a two‐stage approach to detect two biologically plausible genetic loci that can interact with thiazides to increase the risk of thiazide‐associated biochemical abnormalities. Understanding how environmental exposures (including medications such as thiazides) and genetics interact, is an important step toward precision medicine and improved patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperglycemiaHyperuricemiaPolymorphism, Single NucleotideSodium Chloride Symporter InhibitorsAdultAgedFemaleHumansMaleMiddle AgedBiomarkersBlood GlucoseGene-Environment InteractionGenome-Wide Association StudyHypertensionPotassiumQuantitative Trait LociSodiumUK BiobankUnited KingdomUric Acid

Substanzen

BiomarkersBlood GlucosePotassiumSodiumSodium Chloride Symporter InhibitorsUric Acid

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
  • Department of Health Data Science, Institute of Population Health Sciences, University of Liverpool, Liverpool, UK.

ORCID-Profile: Innocent G Asiimwe, Lauren Walker, Reecha Sofat, Andrea L Jorgensen, Munir Pirmohamed

Förderung

  • Medical Research Council

Zitieren

APA

Asiimwe, I. G., Walker, L., Sofat, R., Jorgensen, A. L., Pirmohamed, M., & Multimorbidity Mechanism and Therapeutic Research Collaborative (MMTRC) (2024). Genetic Determinants of Thiazide‐Induced Hyperuricemia, Hyperglycemia, and Urinary Electrolyte Disturbances – A Genome‐Wide Evaluation of the UK Biobank. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3229

Vancouver

Asiimwe IG, Walker L, Sofat R, Jorgensen AL, Pirmohamed M, Multimorbidity Mechanism and Therapeutic Research Collaborative (MMTRC). Genetic Determinants of Thiazide‐Induced Hyperuricemia, Hyperglycemia, and Urinary Electrolyte Disturbances – A Genome‐Wide Evaluation of the UK Biobank. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3229

BibTeX
@article{Asiimwe2024,
  author = {Asiimwe, Innocent G and Walker, Lauren and Sofat, Reecha and Jorgensen, Andrea L and Pirmohamed, Munir and Multimorbidity Mechanism and Therapeutic Research Collaborative (MMTRC), Multimorbidity Mechanism and Therapeutic Research Collaborative (MMTRC)},
  title = {Genetic Determinants of Thiazide‐Induced Hyperuricemia, Hyperglycemia, and Urinary Electrolyte Disturbances – A Genome‐Wide Evaluation of the UK Biobank},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1002/cpt.3229}
}
Kostenlos starten →